Disease Overview：Cushing's syndrome（CS）
Cushing syndrome is a rare endocrine disorder characterized by chronic hypercortisolism—excess cortisol production—resulting from either adrenocorticotropic hormone (ACTH)-dependent causes (e.g., pituitary corticotroph adenoma, ectopic ACTH secretion) or ACTH-independent mechanisms (e.g., adrenal adenoma, carcinoma, or bilateral macronodular hyperplasia). Clinical manifestations include central obesity, moon facies, buffalo hump, proximal muscle weakness, hypertension, glucose intolerance, osteoporosis, and cutaneous striae. Diagnosis relies on dynamic testing—including 24-hour urinary free cortisol, late-night salivary cortisol, and low-dose dexamethasone suppression test—followed by imaging (pituitary MRI, adrenal CT/MRI) and, when indicated, bilateral inferior petrosal sinus sampling. Definitive management depends on etiology: transsphenoidal resection for Cushing disease, adrenalectomy for unilateral adrenal lesions, and medical therapy (e.g., ketoconazole, pasireotide, mitotane) for inoperable or recurrent cases.
China offers distinct advantages for international patients seeking treatment: leading endocrinology centers—such as Peking Union Medical College Hospital and Shanghai Ruijin Hospital—boast multidisciplinary Cushing teams with extensive experience in complex pituitary and adrenal surgery, high-resolution imaging, and molecular diagnostics. Advanced technologies—including intraoperative MRI, rapid intraoperative cortisol assays, and next-generation sequencing for genetic subtyping—enhance diagnostic precision and surgical outcomes. Published 5-year remission rates exceed 70% for microadenomas and 85% for unilateral adrenal tumors. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising quality or safety standards. As a dedicated medical tourism agency, we facilitate seamless care for international patients: coordinating appointments with certified specialists, verifying hospital accreditation, providing itemized, transparent pricing in advance, arranging visas and local logistics, and offering bilingual clinical support throughout diagnosis, treatment, and follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Cushing’s Syndrome (Endocrinology)
Non-Surgical / Medical Management
*Indicated for mild-moderate disease, contraindications to surgery, or preoperative bridging.*
- •First-line Medications
- Drug cost: $45–$90/month (generic, 200 mg × 60 tabs) - Monthly labs (LFTs, cortisol, ACTH): $35 - *Mifepristone*: For hyperglycemia-predominant cases (glucocorticoid receptor antagonist). - Drug cost: $280–$420/month (200 mg × 60 tabs) - Monthly ECG + potassium + glucose: $25 - *Pasireotide*: Reserved for persistent/ectopic cases; requires glucose monitoring. - Injection (60 mg SC monthly): $1,100–$1,450/dose - Monthly HbA1c + fasting glucose + IGF-1: $40
- •Baseline Diagnostic Workup (All Medical Pathways)
- Late-night salivary cortisol ×3: $62 - High-dose dexamethasone suppression test: $75 - Pituitary MRI (1.5T, contrast-enhanced): $220 - Adrenal CT (non-contrast + contrast phases): $185
Surgical / Interventional Options
*First-line for confirmed pituitary adenoma (Cushing’s disease) or adrenal/ectopic tumor.*
- •Transsphenoidal Adenomectomy (Pituitary Surgery)
- Procedure fee (Grade 3A hospital, neuroendocrine team): $3,200–$4,100 - Pre-op IPSS (catheterization + ACTH sampling): $480 - Post-op cortisol replacement (hydrocortisone ×30 days): $18
- •Unilateral Adrenalectomy (Laparoscopic)
- Procedure fee: $3,800–$4,900 - Pre-op AVS (bilateral catheterization + cortisol/aldosterone assay): $560
- •Bilateral Adrenalectomy (Rare, refractory cases)
- Lifelong glucocorticoid/mineralocorticoid replacement included in follow-up.
Special/Complex Scenarios
- •Ectopic ACTH Syndrome (e.g., bronchial carcinoid, thymic NET):
- Resection or peptide receptor radionuclide therapy (PRRT): $4,200–$6,800/course
- •Recurrence after initial surgery: Repeat transsphenoidal surgery: $3,600–$4,400
Quick Selection Guide
- •<40 years, MRI-confirmed microadenoma, no comorbidities: Transsphenoidal surgery ($3,700 avg) — highest cure rate (70–85%).
- •>65 years, severe diabetes/hypertension, surgical risk high: Ketoconazole + metformin ($80/mo total) — safer short-term control.
- •Adrenal carcinoma or ectopic source: Laparoscopic adrenalectomy or tumor resection ($4,300 avg) — definitive oncologic management.
- •Budget-constrained (<$1,000 total): Start with ketoconazole + rigorous lab monitoring ($80/mo) while pursuing public hospital subsidy programs.
- •Recurrent disease post-surgery: Repeat pituitary surgery or bilateral adrenalectomy ($4,100–$5,700) — avoid long-term medical therapy due to cumulative toxicity.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Cushing's syndrome Medical Vacation Packages
Curated transparent all-inclusive packages combining Cushing's syndrome treatment with China top medical destinations:
